Can anyone confirm if the rumour going around that provalis should be revalued at 1.00 a share is true.

The Sun newspaper.... that says it all!

Biotechs in the US (and those in other countries exposed to the US) will start to move seriously in the Spring.

PRO are due to make a progress announcement on G5 before the end of this year - if this is good, factor in the spring effect and postive sales from other revenue streams we could be looking at 40p-50p this time next year. A two year wait for 1.00 (assuming all goes swimmingly) is about right.